FDA could receive additional $500M for COVID-19 vaccines, therapies

Budget legislation released Tuesday by the House Energy and Commerce Committee includes $500 million for FDA to review and facilitate the development and postmarketing surveillance of COVID-19 vaccines and therapeutics, and address drug shortages.

FDA could also put the funding bolus toward advanced continuous manufacturing related to vaccines, and to conduct of inspections related to the manufacturing of vaccines, therapeutics and devices delayed or canceled for reasons related to COVID–19...